Skip to main content
. 2020 Mar 5;38(14):1558–1568. doi: 10.1200/JCO.19.01265

FIG 1.

FIG 1.

Study flow diagram. Patients enrolled in AREN0321 by stage and response to treatment with vincristine and irinotecan (VI) window. (*)Although a partial response was achieved, the treating physician elected to treat with revised regimen UH1.